Study of postpregnant osteoporosis

Efficacy of calcium supplementation for postpregnant osteoporosis.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs071200097

Enrollment

Registered

2021-02-08

Start date

2021-04-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postpregnancy osteoporosis pregnancy osteoporosis

Interventions

armA Calcium supplementation (2 Tab/day, 1year) armB Non medication

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. over 20 years of age 2. Within 1month +/- 1 month after delivery 3. Puerperant who comes Nagasaki University Hospital 4. Under 25 of BMI at non-pregnacy 5. obtained informed consent

Exclusion criteria

Exclusion criteria: 1. Under 20 years of age 2. Use of medicines for osteoporosis 3. Bone diseases and receive treatment 4. Use calcium supplement 5. Pregnancy 6. Unable to sit 7. Obesity 8. inadequate patients

Design outcomes

Primary

Measure	Time frame
Lumber BMD at 6-month after delivery	—

Secondary

Measure	Time frame
Bone microstructure Holmone Bone metabolic markers	—

Contacts

Public ContactYuriko Kitajima

Nagasaki University

yurikokitajima@nagasaki-u.ac.jp+81-95-819-7363

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026